Skip to main content
. 2016 Sep 20;7(43):70080–70091. doi: 10.18632/oncotarget.12148

Figure 6. Increased expression of FRMD6 inhibits activities of several receptor tyrosine kinases (RTKs).

Figure 6

(A–B) Equal amounts of protein lysates derived from U87MG-control (A-bottom panel), U87MG-FRMD6 (A-upper panel), U251-control (B-bottom panel) and U251-FRMD6 (B-upper panel) cells were applied to the Proteome Profiler Human Phospho-RTK Array membranes. Analyses of the phospho-receptor tyrosine kinase (RTK) arrays were performed following the manufacturer's instructions (R&D Systems). The squares and small/large/intermediate circles highlight positive controls, phospho-c-Met, phospho-PDGFRα/β, and phospho-RYK, respectively.